https://apnews.com/article/wegovy-zepbound-obesity-drugs-coverage-access-142e234c16df4443e8f66c27d01f44e2
Prices are falling for the popular obesity treatments Wegovy and Zepbound, but steady access to the drugs remains challenging. Reduced monthly costs for uninsured patients still amount to around $500. That can put the drugs out of reach for many. Coverage als…
Create an account or login to join the discussion